Frost Radar：機器人手術設備，2025年

Frost Radar: Robotic Assisted Surgical Devices, 2025

出版日期: 2025年08月29日 | 出版商:

Frost & Sullivan | 英文 22 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

推動公司採取行動的基準化分析系統 - 推動新交易流程和成長管道的創新

機器人輔助手術設備（RASD）透過提高複雜手術的精確度、靈活性和控制力，徹底改變了外科手術實踐。機器人技術能夠協助外科醫生進行人體工學設計、運動縮放和震顫過濾。依服務收費和租賃選項可以緩解對高昂購置和維護成本的擔憂。

本分析對領先的供應商進行了基準測試，因為機器人系統的最新創新，例如改進的觸覺回饋、整合人工智慧和微型化設計，目的是突破局限性並擴大微創手術的範圍。本文重點介紹了機器人輔助手術的變革性作用，並深入探討了最佳化其臨床應用的未來方向，以及高昂的成本、培訓要求以及進一步縱向研究以建立標準化通訊協定的必要性。

Frost & Sullivan 會分析同一產業內的眾多公司。會根據領導力或其他卓越表現，對入選進行進一步分析的公司進行 10 項成長和創新標準基準測試，以揭示其在 Frost Radar™ 上的排名。本上市公司會為 Frost Radar™ 上的每一家公司提供競爭概況，探討每家公司的優勢以及與這些優勢最契合的機會。

策略要務與成長環境

策略要務

手術機器人公司加大對人工智慧（AI）、機器學習、擴增實境（AR）和 5G 的投資，以提高手術精度、可視化和遠端手術能力。重點是人工智慧輔助機器人，以改善決策並減少錯誤，而小型移動機器人解決方案則解決了設置時間和成本方面的障礙。
機器人技術可協助外科醫生實現人體工學、運動縮放和震顫過濾。各公司正致力於透過擴展培訓計畫和研討會（例如 Intuitive Surgical 的獎學金計畫）來解決從腹腔鏡外科醫生過渡到機器人外科醫生過程中的陡峭學習曲線。與醫院的合作提供了實務經驗，促進了機器人技術的採用，尤其是在整形外科和研討會領域。
成功的合併、收購和合作擴大了機器人輔助手術設備（RASD）的產品系列和市場佔有率，例如 Asensus Surgical 收購 KARL STORZ 以及 Stryker 與 Synaptive Medical 合作以增強可視化和手術引導能力。
亞太地區、中東和非洲等高成長地區可能青睞那些提供經濟高效的系統和客製化解決方案的公司。Medtronic的Hugo RAS系統等模組化設計可以提高醫療保健支出不斷成長的新興市場的可負擔性和可近性。
付費模式和租賃選項，就像在南非部署達文西一樣，可以減輕人們對高昂的購買和維護成本的擔憂。
Frost & Sullivan 預測，隨著醫療設施的去中心化，機器人手術將更加普及。受文明病的增多以及對平價醫療服務需求的不斷成長的推動，使用機器人設備的機器人手術徹底改變醫療成本的降低方式。

成長環境

美國食品藥物管理局（FDA）的核准和歐洲 CE 標誌認證等法律規範對市場准入和應用有重大影響。不斷擴展的監管法規能夠擴大臨床應用，進而提升整個領域的採用率、收益潛力和創新。這一發展與一個支持性生態系統相吻合，該生態系統的特點是微創手術需求旺盛、人工智慧和機器人技術日益融合、全球人口老化以及醫療保健投資不斷增加。
受人口老化和慢性疾病（如癌症和心血管疾病）流行的影響，手術量不斷增加，這推動了對系統、儀器和配件的需求增加，直接提高了收益。雖然 RASD 在泌尿系統和婦科領域已很成熟，但技術進步和臨床證據擴展到其他高成長專業，其中神經外科和整形外科最有前景。神經外科中的RASD 是由人工智慧引導的腦外科手術精準度以及 ROSA ONE Brain 和 ZEISS KINEVO 900 等平台驅動的，而整形外科在關節關節重建和脊柱手術方面繼續保持強勁成長，這得益於觸覺微鉗等創新和退化性疾病的興起。
像 Intuitive Surgical 這樣的老牌公司面臨著來自提供創新、低成本系統的競爭對手日益激烈的競爭，這些競爭對手包括 CMR Surgical（Versius）、Asensus Surgical 和 Medtronic（Hugo RAS）。受成本效益和患者偏好的驅動，向門診手術中心（ASC）和門診設施的轉變加速。在美國， ASC 每年可節省 380億美元的成本。
RASD 廣泛應用於關節重建和髖置換術等高精度、微創手術，美國每年進行超過 790,000 例膝關節關節重建和 544,000 例髖置換術。

最佳實踐和成長機會

價值主張解決客戶痛點，並積極將客戶回饋納入研發和創新中。
經過驗證的產品績效和投資報酬率直接支援客戶目標和成功指標，包括提高工作流程效率、品質和財務成果。
人工智慧、機器學習和大規模語言模型等技術能力與行業趨勢保持一致，並結合了有機和無機策略。

最佳實踐和成長機會

透過整合人工智慧主導的分析和即時資料處理，混合系統可以提升手術精度，超越現有系統。透過將機器人的靈活性與自適應學習能力相結合，這些設備可以減少手術時間並減少人為錯誤，吸引那些希望最佳化手術結果和手術量的患者和醫院。
果凍的範圍可以擴大到包括常規手術，一名外科醫生可以監督多個手術室，甚至可以進行太空探勘，正如 Space MIRA 在2024年測試的那樣。人工智慧的整合，正如中國最近的例子所示，表明未來該領域的潛力更大，機器人可以協助甚至部分自動化任務。
借助人工智慧，資料和複雜演算法可以確定模式，並以亞毫米級的精度控制機器人手術。人工智慧和機器視覺可以分析掃描結果，檢測出通常會被遺漏的癌症。人工智慧驅動的腹腔鏡視訊分析有助於即時識別手術和介入過程中遺漏或意外的步驟。

非公路設備細分

農業設備
農用曳引機
聯合收割機
其他
捆包機
農用割草機
噴霧器和撒佈機
切碎機
割曬機
施工機械
壓實機
起重機
推土機
自動卸貨卡車
挖土機
裝載機
平土機
攪拌機
鋪路車
滾壓機
鏟運機
加長型堆高機
挖溝機
小型和微型挖土機
緊湊型和小型裝載機與先前的展望相比，該系列新增了
礦山機械
壓實機
起重機
推土機
自動卸貨卡車
挖土機
裝載機
平土機
鋪路車
滾壓機
鏟運機
挖溝機

Robotic-assisted surgical devices (RASDs) have transformed surgical practice by enhancing precision, dexterity, and control during complex procedures. Robotic technology helps surgeons in terms of ergonomics, motion scaling, and tremor filtration. Pay-per-use models or leasing options can alleviate concerns about high acquisition and maintenance costs.

This analysis benchmarks leading vendors whose recent innovations in robotic systems, such as improved haptic feedback, artificial intelligence integration, and miniaturized designs, aim to address limitations and expand the scope of minimally invasive surgery. It underscores the transformative role of robotic assistance in surgery and provides insights into future directions for optimizing its clinical application, high costs, training requirements, and the need for further long-term studies to establish standardized protocols.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.

Strategic Imperative and Growth Environment

Strategic Imperative

Surgical robot companies are increasing investments in artificial intelligence (AI), machine learning, augmented reality (AR), and 5G to enhance surgical precision, visualization, and remote surgery (telesurgery) capabilities. The focus is on AI-assisted robots for improving decision-making and reducing errors, while smaller, mobile robotic solutions address setup time and cost barriers.
Robotic technology helps surgeons in terms of ergonomics, motion scaling, and tremor filtration. Companies aim to address the steep learning curve of transitioning from a laparoscopic surgeon to a robotic surgeon by scaling training programs and workshops, such as Intuitive Surgical's fellowship programs. Partnerships with hospitals provide hands-on experience and are boosting adoption, especially in orthopedics and neurosurgery.
Successful mergers, acquisitions, or collaborations expand robotic-assisted surgical device (RASD) product portfolios and market share. Examples include Asensus Surgical's acquisition of KARL STORZ and Stryker's partnerships with Synaptive Medical to enhance capabilities in visualization and surgical guidance.
High-growth regions, such as Asia-Pacific and the Middle East and Africa, can be lucrative for companies that offer cost-effective systems and tailored solutions. Modular designs, such as Medtronic's Hugo RAS system, can improve affordability and accessibility in emerging markets that are spending more on healthcare.
Pay-per-use models or leasing options, as seen with South Africa's Da Vinci adoption, can alleviate concerns about high acquisition and maintenance costs.
Frost & Sullivan expects the decentralization of institutions to bring about more offerings with robotic surgeries. Influenced by the growing incidence of lifestyle diseases and rising demand for affordable healthcare, robotic surgery with robotic devices is transforming the cost of treatment declines.

Growth Environment

Regulatory frameworks, such as US Food and Drug Administration (FDA) approvals or CE mark certifications in Europe, significantly affect market entry and adoption. Regulatory expansions are enabling broader clinical applications, thereby boosting adoption rates, revenue potential, and technological innovation across the sector. This development aligns with a supportive ecosystem characterized by demand for minimally invasive surgeries, advancements in AI and robotics integration, an aging global population, and increasing healthcare investments.
Rising procedure volumes, driven by an aging population and chronic disease prevalence (e.g., cancer and cardiovascular issues) increase demand for systems, instruments, and accessories, directly boosting revenue. While established in urology and gynecology, RASDs are expanding into specialties with high growth potential because of technological enhancements and clinical evidence. The most promising include neurosurgery and orthopedics. RASDs in neurosurgery are driven by AI-guided precision for brain surgeries and platforms like ROSA ONE Brain or ZEISS KINEVO 900, while orthopedics continues to experience strong growth in joint replacements and spine surgeries, supported by innovations such as haptic micro-forceps and an increase in degenerative diseases.
Intuitive Surgical and other established companies face growing competition from new entrants, such as CMR Surgical (Versius), Asensus Surgical, and Medtronic (Hugo RAS), that offer innovative, often lower-cost systems, increasing pricing pressure and making RAS more accessible. The shift to ambulatory surgery centers (ASCs) and outpatient facilities is accelerating, driven by cost-effectiveness and patient preference. ASCs save $38 billion annually in the United States.
RASD are widely used in procedures that benefit from high precision and minimal invasiveness, including knee and hip replacements, with more than 790,000 knee replacements and 544,000 hip replacements performed annually in the United States.

Best Practices & Growth Opportunities

A value proposition addresses client pain points and proactively integrates client feedback in R&D and innovation.
Proven product performance and ROI directly support client goals and success metrics, such as improvements in workflow efficiency, quality, and financial outcomes.
Technological capabilities, such as AI, ML, and large language models, align with industry trends through an appropriate combination of organic and inorganic strategies.

Best Practices & Growth Opportunities

Hybrid systems could integrate AI-driven analytics and real-time data processing to improve surgical precision beyond what current systems offer. By combining robotic dexterity with adaptive learning capabilities, these devices might reduce operative times and human error, appealing to surgeons and hospitals aiming to optimize outcomes and throughput.
Telesurgery's scope could expand to routine procedures in which one surgeon oversees multiple operating rooms, or even to space exploration, as tested with SpaceMIRA in 2024. The integration of AI, as seen in China's recent cases, suggests a future where robots might assist or partially automate tasks, further broadening the field's potential.
With AI, data and complex algorithms can determine patterns to control robots' surgical accuracy to submillimeter precision. AI and machine vision can analyze scans and detect cancerous cases that would otherwise be missed. AI laparoscopic video analysis will help identify missing or unexpected steps in real time during a procedure or intervention.

Segmentation Off-Highway Equipment